baber/WOPTO huggingface dataset:
Patent MX-2022005565-A (MX)
Title: RGMa BINDING PROTEIN AND USE THEREOF.
Inventor: HASHIMOTO MOTONORI
IPC: C07K16/28
Filed: 2017-10-27
Abstract: The present invention addresses the problem of obtaining an anti-repulsive guidance molecule a (RGMa) antibody which has a high binding activity and few side effects and can be used as a medicine for preventing, treating, or preventing the relapse of neurological or immunological diseases. Said problem is solved by providing an isolated RGMa binding protein which does not inhibit binding between RGMa and neogenin, but neutralizes the neuritis growth inhibiting activity of RGMa, and preferably by providing an anti-RGMa antibody which has a complementarity determining region having an amino acid sequence of SEQ ID NOS: 30-35 or SEQ ID NOS: 36-40 in the sequence listing, and SFG.
Patent MX-2022011989-A (MX)
Title: A two-terminal device.
Inventor: MCARDLE TREVOR
IPC: H01L31/0352
Filed: 2021-03-23
Abstract: There is provided a two-terminal device, including a substrate comprising a first cell having a first characteristic resistance, and a second cell, spaced apart from the first cell along the web direction of the substrate, having a second characteristic resistance; a first terminal and a second terminal, each terminal being formed towards or at opposing edges of the substrate across the transverse direction, and each terminal being in electrical communication with the first cell and the second cell; and a connecting portion, between the first cell and the second cell, the connecting portion having a third characteristic resistance; wherein the third characteristic resistance is greater than or equal to at least one of the first characteristic resistance and the second characteristic resistance. There is also provided a method of forming such a two-terminal device).
Patent MX-2022012201-A (MX)
Title: Hydroformylation catalyst system with syngas surrogate.
Inventor: JAUNKY PIOTR
IPC: B01J31/20
Filed: 2021-03-26
Abstract: Described herein is a hydroformylation catalyst system and method useful for producing aldehydes from olefin substrates, without using carbon monoxide gas. The hydroformylation catalyst system includes a hydroformylation catalyst complex including a Group 9 metal complexed with a phosphine-based ligand; a syngas surrogate including formic acid and an anhydride compound, which forms carbon monoxide in situ; and hydrogen, which may derive from the syngas surrogate or not derived from the syngas surrogate. The method involves reacting the olefin substrate with a syngas surrogate in the presence of a hydroformylation catalyst complex, wherein the syngas surrogate forms carbon monoxide, and optionally hydrogen, in situ, and then isolating the aldehyde compound from a reaction mixture.
Patent MX-2022013486-A (MX)
Title: Apparatus and method for deforming the conductors of at least one winding assembly, protruding from a side of a stator or rotor of an electric machine.
Inventor: RUGGIERI GIOVANNI
IPC: H02K15/00
Filed: 2021-10-29
Abstract: An apparatus (200) for deforming conductors of at least one winding assembly (100), protruding from a side of a stator or rotor (114) of an electric machine, which comprises a plurality of base conductors (102) each arranged with at least one leg (104, 106) inserted into cavities (115) of stator or rotor (114), each having at least one respective free end (108, 110). The apparatus comprises at least one twisting matrix (201) adapted to rotate about an axis (X), comprising at least one pocket (204) adapted to insert a free end portion (108, 110). The apparatus (200) comprises a radial backing member (300) provided close to the at least one twisting matrix (201), and in particular close to the at least one pocket (204), on the insertion side of said free end (108, 110). The radial backing member (300) comprises an inner radial backing surface (302) for a portion of leg (104, 106) protruding from said side of said stator or rotor (114).
Patent MX-2022015714-A (MX)
Title: Effervescent oral composition comprising an active ingredient.
Inventor: ZAWADZKI MICHAEL ANDREW
IPC: A23P10/30
Filed: 2021-06-03
Abstract: The disclosure provides an effervescent composition adapted for oral use, the composition including an effervescent material; one or more fillers in a total amount of at least about 30% by weight, the one or more fillers including at least one sugar alcohol; at least one active ingredient; and optionally, a lipid in an amount of at least about 20% by weight. Melting effervescent compositions are also provided, which include the lipid.
Patent MX-2022015755-A (MX)
Title: Pth prodrugs.
Inventor: ZETTLER JOACHIM
IPC: A61K47/56
Filed: 2018-08-16
Abstract: The present invention relates to PTH prodrugs, pharmaceutical compositions comprising such PTH prodrugs and their uses.
Patent MX-2022015931-A (MX)
Title: Overload protection for a lock structure.
Inventor: Möller Per
IPC: A47K10/32
Filed: 2020-06-22
Abstract: A lock structure is provided for use with a dispenser comprising a housing have an interior volume for holding a dispensable product, the housing having an openable part for providing access to the interior of the housing. The lock structure has a lock housing, a latch operable between a locked position and an unlocked position, a lock cylinder structure comprising a rotation means insert portion, and a resilient member for biasing the latch toward the locked position. The lock structure is provided with an overload protection mechanism formed by a resilient obstruction positioned to define an extreme position that corresponds to the locked or unlocked position of the latch and is adapted to give way upon experiencing an overload force to allow the lock cylinder structure to rotate beyond the extreme position.
Patent MX-JL06000017-A (MX)
Title: System and method for radar-assisted catheter guidance and control.
Inventor: SHACHAR JEHOSHUA
IPC: A61M31/00
Filed: 2004-10-20
Abstract: A Catheter Guidance Control and Imaging (CGCI) system whereby a magnetic tip attached to a surgical tool is detected, displayed and influenced positionally so as to allow diagnostic and therapeutic procedures to be performed is described. The tools that can be so equipped include catheters, guidewires, and secondary tools such as lasers and balloons. The magnetic tip performs two functions. First, it allows the position and orientation of the tip to be determined by using a radar system such as, for example, a radar range finder or radar imaging system. Incorporating the radar system allows the CGCI apparatus to detect accurately the position, orientation and rotation of the surgical tool embedded in a patient during surgery. In one embodiment, the image generated by the radar is displayed with the operating room imagery equipment such as, for example, X-ray, Fluoroscopy, Ultrasound, MRI, CAT-Scan, PET-Scan, etc. In one embodiment, the image is synchronized with the aid of fiduciary markers located by a 6-Degrees of Freedom (6-DOF) sensor. The CGCI apparatus combined with the radar and the 6-DOF sensor allows the tool tip to be pulled, pushed, turned, and forcefully held in the desired position by applying an appropriate magnetic field external to the patient's body. A virtual representation of the magnetic tip serves as an operator control. This control possesses a one-to-one positional relationship with the magnetic tip inside the patient's body. Additionally, this control provides tactile feedback to the operator's hands in the appropriate axis or axes if the magnetic tip encounters an obstacle. The output of this control combined with the magnetic tip position and orientation feedback allows a servo system to control the external magnetic field.
Patent MX-PA00012517-A (MX)
Title: Test, reset and communications operations in an arc fault.
Inventor: WONG KON B
IPC: H02H3/10
Filed: 2000-12-15
Abstract: CIRCUIT INTERRUPTER WITH OPTIONAL MEMORY AND/OR BACKUP POWER An arc fault circuit interrupter system for use with an electrical circuit includes an arcing fault detector which monitors the electrical circuit and a controller which generates a trip signal in response to the detection of arcing faults. The controller may also generate one or more communication signals corresponding to information relating to the operation of the arcing fault circuit interrupter. The system may also include one or more of the following: a communication port which communicates to a user the information relating to operation of the arc fault circuit interrupter in response to the communication signals; a memory for retaining predetermined information related to the condition and operation of the arcing fault circuit interrupter, with or without a backup memory; and a combined self-test/reset switch.
Patent MX-PA01009655-A (MX)
Title: Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof.
Inventor: HOGENKAMP DERK J
IPC: C07D277/32
Filed: 2000-03-24
Abstract: This invention relates to compounds having Formula (I) or a pharmaceutically acceptable salt, prodrug or solvate thereof, wherein Het and R5-R13 are set in the specification. The invention also is directed to the use of compounds of Formula (I) for the treatment of neuronal damage following global and focal ischemia, for the treatment or prevention of neurodegenerative conditions such as amyotrophic lateral sclerosis (ALS), and for the treatment, prevention or amelioration of both acute or chronic pain, as antitinnitus agents, as anticonvulsants, and as antimanic depressants, as local anesthetics, as antiarrhythmics and for the treatment or prevention of diabetic neuropathy.
Patent MX-PA01010947-A (MX)
Title: Treating compositions comprising polysaccharides.
Inventor: BARNABAS MARY VIJAYARANI
IPC: C11D3/22
Filed: 2000-04-25
Abstract: The present invention relates to treating compositions, preferably laundry and/or fabric and/or color care compositions comprising polysaccharides, and methods of using such compositions to provide improved color appearance and/or pill prevention and/or abrasion resistance and/or wrinkle resistance and/or shrinkage resistance benefits, while at the same time providing improved cleaning benefits, over laundry and/or fabric and/or color care compositions without such polysaccharides.
Patent MX-PA01013442-A (MX)
Title: Closure device for a medical container.
Inventor: EEK ARNE
IPC: A61J1/00
Filed: 2000-07-05
Abstract: A closure device is designed for attachment on a neck portion (1) of a separate container (2), preferably of glass material, which holds a first substance. The closure device defines a passage (10) extending between opposite first and second openings (11, 13) of the closure device. A sealing means (30) is arranged to close off the first opening (11) and confine a second substance in the passage (10). A penetration means (33) is incorporated in the device and operable to penetrate the sealing means (30) such that fluid communication is established between the passage (10) and the container (2). In a method of mixing the first and second substances, a medical practitioner exposes the second opening (13) by removing a non-resealable cap (8), by introducing and engaging the end of a syringe directly in the second opening (13), and by operating the penetration means (33) to penetrate the sealing means (30). By operating the syringe, the practitioner can transfer the first and second substances to the syringe, and mix the same in the process, with minimum need for sterilization.
Patent MX-PA02004947-A (MX)
Title: Treatment of crude oils.
Inventor: RODOLFO ANTONIO M GOMEZ
IPC: C10G27/04
Filed: 2000-11-13
Abstract: A process and apparatus to extract and recover heavy metals and sulfur from crude oil (3) or petroleum fuel products consisting of the steps of emulsifying (4) the crude oil with an emulsifying agent (5), adding a leach solution (14, 17) to the emulsified crude oil and leaching (7) the emulsified crude oil at elevated temperature and pressure to give a leached emulsified crude oil. The leach solution may be acid or alkali. A proportion of the leach solution (16) is extracted for recovering heavy metals. There can also be a microwave hydro treating step (9) using hydrogen gas (10) at a temperature below 220 C to ensure there is no quality degradation in the crude feed to produce a desulfurised crude oil (20) and a hydrogen sulphide by product and recovering sulfur from the hydrogen sulphide by product.
Patent MX-PA02008371-A (MX)
Title: Pyrimidine compounds.
Inventor: BRADBURY ROBERT HUGH
IPC: A61P29/00
Filed: 2001-02-26
Abstract: Pyrimidine derivatives of the formula (I) wherein: one of Q1 and Q2 or both of Q1 and Q2 is substituted on a ring carbon by one substituent of the formula (Ia) [provided that when present in Q1 the substituent of formula (Ia) is not adjacent to the NH link]; wherein Q1, Q2, G, R1, X, Y1, Y2, Z, n and m are as described within; and pharmaceutically acceptable salts and in vivo hydrolysable esters thereof are described. Processes for their manufacture, pharmaceutical compositions and their use as cyclin dependent serine threonine kinase (CDK) and focal adhesion kinase (FAK) inhibitors are also described.
Patent MX-PA02010023-A (MX)
Title: Transparent medium having angle selective transmission or reflection properties and or absorption properties.
Inventor: SCHMIDT CHRISTOPH
IPC: C09D5/32
Filed: 2001-03-20
Abstract: The invention relates to a transparent medium that contains multilayer pigments having angle selective reflection or transmission properties and or absorption properties, and to the use thereof, in particular, in transparent heat insulating (THI) systems.
Patent MX-PA02010028-A (MX)
Title: Hypotensors.
Inventor: MURAKAMI KAZUO
IPC: A61K38/00
Filed: 2001-04-09
Abstract: A method of selecting a substance capable of controlling the activation of prorenin with the use of, as an indication, the ability to control the activation of prorenin by an interaction between proteins in the profragment domain of prorenin; a prorenin activation controlling substance which has a function of controlling the activation of prorenin based on the interaction between proteins in the profragment domain of prorenin; and hypotensors, organ overgrowth inhibitors and arterial thickening inhibitors containing the above described prorenin activation controlling substance as the active ingredient.
Patent MX-PA02011674-A (MX)
Title: Flame resistant rendering heat treating device, and operation method for the device.
Inventor: YAMAGUCHI MASANAO
IPC: D01F9/32
Filed: 2002-03-20
Abstract: A flame resistant rendering heat treating device comprising a flame resistant rendering furnace provided with a heat treating chamber having a plurality of slits through which polyacrylonitrile fiber strands, parallel-running while being reversed in direction, enter or exit and supplying hot air vertically from above the fiber strands to render them flame resistant and with a hot air supplying means, and a plurality of reversing rollers provided on the opposite outer sides of the furnace, for turning back fiber strands passing through the slits to return them to the furnace, wherein a clearance between the heat treating chamber's side wall parallel to the direction of fiber strands running in the chamber and fiber strands, or a clearance between a drift prevention plate inserted in parallel to the strands' running direction to between the fiber strands and the side wall and fiber strands is formed to be up to 150 mm, slits being possibly provided with a heated air supplying means.
Patent MX-PA03004665-A (MX)
Title: Parsed program guide data.
Inventor: ALAN EDWARD SHIELD
IPC: H04N7/16
Filed: 2003-05-27
Abstract: A program guide data system is described that parses program guide data into data sections such that program guide data corresponding to a program is distributed into one or more of the data sections. A program guide data file is generated that includes the data sections and the program guide data file is communicated to client devices. In an implementation, the data sections are similarly formatted to include various element data types that contain the program guide data and/or are indexes to additional data sections that contain the program guide data.
Patent MX-PA03009754-A (MX)
Title: Method and device for producing an aqueous acrylamide solution using a biocatalyst.
Inventor: OLAF PETERSEN
IPC: B01J14/00
Filed: 2002-04-25
Abstract: The invention relates to a method and a device for producing an aqueous acrylamide solution by the hydration of acrylnitrile in an aqueous solution in the presence of a biocatalyst.
Patent MX-PA03010341-A (MX)
Title: Use of compounds with combined nep/mp-inhibitory activity in the preparation of medicaments.
Inventor: DIETER ZIEGLER
IPC: A61P13/12
Filed: 2002-05-14
Abstract: This invention relates to the use of a compound having combined, in particular concurrent, inhibitorz activity on neutral endopeptidase (NEP) and on a novel metalloprotease designated IGS5, or of a pharmaceutically acceptable salt or solvate or biolabile ester thereof, for the manufacture of a medicament (pharmaceutical composition) for treating a larger mammal, preferably a human, suffering from or being susceptible to a disease or condition which can be alleviated or prevented by combined or concurrent inhibition of NEP and IGS5. In a particular aspect the present invention pertains to the use of said compounds with combined or concurrent NEP/IGS5 inhibitory activity for treating a larger mammal, preferably a human, suffering from or being susceptible to a disease or condition where bit-ET-l levels are elevated and which disease or condition can be alleviated or prevented by cobined or concurrent inhibition of NEP and IGS5. In a further particular aspect the present invention pertainsto the use of said compounds with combined or concurrent NEP/IGS5 inhibitory activity for treating a larger mammal, preferably a human, suffering from or being susceptible to a disease or condition where ET-1 is significantly upregulated and which disease or condition can be alleviated or prevented by combined or concurrent inhibition of NEP and IGS5. In the present invention said compounds with combined or concurrent NEP/IGS5-inhibitory activity preferably are used for the treatment and/or prophylaxis of hypertension, including secondary forms of hypertension such as renal or pulmonary hypertension, heart failure, angina pectoris, arrhythmias, myorcadial infarction, cardiac hypertrophy, cerebral ischemia, peripheral vascular disease, subarachnoidal hemorrhage, chronic obstructive pulmonary disease (COPD), asthma, renal disease, atherosclerosis, and pain in colorectal cancer or prostate cancer, in mammals, preferably in humans, and more preferably in a patient sub-population suffering from or being susceptible to a disease or condition which can be alleviated or prevented by combined or concurrent inhibition of NEP and IGS5. Furthermore, it may be beneficial to additionally combine the said compounds showing combined or concurrent NEP/IGS5 inhibitory activity with other individual and/or combined metalloprotease inhibitors than the NEP/IGS5 inhibitors, e.g. with separate ACE- and/or NEP-inhibitors and/or mixed inhibitors of these metalloproteases.
Patent MX-PA04000987-A (MX)
Title: System admixture compensation system and method.
Inventor: CHARLES MARTINEZ
IPC: H04N1/407
Filed: 2002-07-19
Abstract: A method provides reference profile density values for at least one color combination having a plurality of colors produced by a reference device using a reference colorant set, at least one overprint color combination having reference initial percent dot values (IPDVs); providing current profile density values for at least one color combination produced by a current device using a current colorant set, at least one color combination produced by the current colorant set having current IPDVs (302); quantifying current TPDVs as efficiency attributes using the current colorant set (304); and calculating factors that compensate for at least one difference between image data produced with the reference colorant set and image data to be printed with the current colorant set in response to reference efficiency attributes and current efficiency attributes, factors used to adjust and generate image data (306-310).
Patent MX-PA04001648-A (MX)
Title: Laryngeal mask airway device.
Inventor: ARCHIBALD IAN JEREMY BRAIN
IPC: A61M16/04
Filed: 2002-08-21
Abstract: A laryngeal mask airway device (4900) has its airway tube (4810) attached to the pharyngeal side of the toroidal inflatable cuff (4960) thereby to increase the depth of the interior aperture of the device and to increase the seal with the patient's anatomy.
Patent MX-PA04002287-A (MX)
Title: Process for the preparation of hydroxy-vinyl-aromatic polymers or copolymers by anionic or controlled radical polymerization.
Inventor: PETER NESVADBA
IPC: G03F7/033
Filed: 2002-09-02
Abstract: The instant invention relates to a process for the preparation of hydroxy-vinyl-aromatic polymers in particular 4-hydroxystyrene polymers or copolymers by anionic or controlled radical polymerization of the respective monomer, wherein the hydroxy functionality is blocked with a protective group which is subsequently removed in a hydrogenation process. The resulting (co)polymers have a narrow polydispersity and are useful for manufacturing photoresists.
Patent MX-PA04008974-A (MX)
Title: A method and apparatus for wireless remote telemetry using ad-hoc networks.
Inventor: SAMIR S SOLIMAN
IPC: G08C17/02
Filed: 2003-03-13
Abstract: A wireless remote telemetry system uses low-cost, low-power ad-hoc networks to provide flexible reading and control of remote devices. In an embodiment applicable to a utility service, consumption of electrical power among a population of customers is measured by a utility metering system having ad-hoc network communication capability. The remote metering unit transmits information over an ad-hoc network to one or more intermediate communication units or hops. The intermediate communication units or hops include a mobile unit, a mobile base unit, a subscriber home computer, and a home base unit. Each of these hops may co-exist in the same large-scale system. The intermediate communication units transfer the received information to a central controller through multi-hop ad-hoc networks or cellular networks, according to intelligent planning by the wireless infrastructure or the central unit.
Patent MX-PA04012688-A (MX)
Title: Transport and storage containers for liquids.
Inventor: UDO SCHUETZ
IPC: B65D90/20
Filed: 2004-12-15
Abstract: A transport and storage container for liquids has an exchangeable inner plastic container and a pallet-shaped support frame on which the inner container rests. The inner container has four walls, each having a continuously smooth outer surface, a bottom and a top wall, and a filling spout and a drainage spout for receiving a drainage fixture. The transport and storage container also has an outer jacket for receiving the inner container, wherein the outer jacket is a sheet metal jacket or a grid jacket. The transport and storage container has a tamperproofing device in that at least one projection is formed as a unitary part of a support frame bottom of the support frame. At least one recess is formed as a unitary part of a lower bottom area of the inner container. The recess has a shape matching the shape of the projection so that the projection engages the recess.
Patent MX-PA04012734-A (MX)
Title: Water treatment apparatus.
Inventor: VERNON JAMES DONNELLY
IPC: C02F1/28
Filed: 2003-08-07
Abstract: A water treatment cartridge (1) has major and a minor axis in a horizontal cross-section and mounting lugs (20) provided at the upper end of the cartridge (1), generally aligned with the major axis of the cartridge (1).